Summit Wealth Group (Colorado)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,146
Closed -$552K 310
2025
Q3
$552K Buy
+2,146
New +$290K 0.06% 249

Other funds holding BIIB

Summit Wealth Group (Colorado)'s BIIB Position: Q4 2025 in Review

Summit Wealth Group (Colorado) sold out of Biogen (BIIB) in Q4 2025, closing a stake of 2,146 shares — an estimated $552K sold.

Summit Wealth Group (Colorado) first reported a position in BIIB in Q3 2025 and held it in 1 quarter. The position peaked at $552K in Q3 2025. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Summit Wealth Group (Colorado) reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Summit Wealth Group (Colorado) sold 2,146 Biogen shares in Q4 2025, an estimated $552K.
  • Summit Wealth Group (Colorado) first reported a position in Biogen in Q3 2025 and held it in 1 quarter.
  • Summit Wealth Group (Colorado)'s Biogen position peaked at $552K in Q3 2025.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q4 2025, filed 4 Feb 2026.